Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kelonia Therapeutics, Inc.

Clinical trials sponsored by Kelonia Therapeutics, Inc., explained in plain language.

Trials to join now! 1

New gene therapy trial offers hope for Tough-to-Treat blood cancer

Disease control Recruiting now

This early-stage trial is testing the safety of a new gene therapy called KLN-1010 for people with multiple myeloma that has returned or stopped responding to other treatments. The therapy works by modifying the patient's own immune cells inside the body to better target cancer c…

Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC